RBC Capital Markets said Xoma Ltd. (NASDAQ: XOMA) continues to make steady albeit measured progress toward initiating a pivotal trial in Behcet’s disease, which could begin by year-end 2011, pending regulatory feedback.
According to the federal Food and Drug Administration (FDA), the consumption of raw milk holds potential health risks because of the dangerous microorganisms it contains. Despite the warning from the FDA, raw milk drinkers and producers defy it. They say it is a healthier approach in drinking milk
Roche Holding AG's rheumatoid arthritis drug Actemra received approval from the U.S. Food and Drug Administration (FDA) to treat a rare type of arthritis in children.
The top after-market NASDAQ Stock Market gainers are: Xenoport, Bed Bath & Beyond, Immucor, Fortinet, and Tesco. The top after-market NASDAQ Stock Market losers are: Power-One, Tuesday Morning, Advanced Analogic Technologies, ISTA Pharmaceuticals, and Lincare Holdings.
Pfizer Inc. (NYSE: PFE) will close its research and development (R&D) facility in Sandwich, Kent, England, which presently employs 2,400 people, the “majority” of which would be made redundant over the next two years.
German researchers say they have cured a man of HIV infection that could prove to be a scientific advance but researchers familiar with the work feel it is not necessarily a treatment advance.
A team of U.K. scientists found evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother.